Tuberous sclerosis complex exhibits a new renal cystogenic mechanism. Issue 2 (23rd January 2019)

• Record Type: Journal Article
• Authors: Bissler, John J.; Zadjali, Fahad; Bridges, Dave; Astrinidis, Aristotelis; Barone, Sharon; Yao, Ying; Redd, JeAnna R.; Siroky, Brian J.; Wang, Yanqing; Finley, Joel T.; Rusiniak, Michael E.; Baumann, Heinz; Zahedi, Kamyar; Gross, Kenneth W.; Soleimani, Manoocher
• Is Part Of: Physiological reports. Volume 7:Issue 2(2019)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2019-01-23
• Subjects: Intercalated cells -- renal cystic disease -- renal cystogenesis -- Tuberous sclerosis complex; Physiology -- Periodicals; 571
• DOI: 10.14814/phy2.13983
• Languages: English
• ISSNs: 2051-817X

Abstract

Abstract: Tuberous sclerosis complex (TSC) is a tumor predisposition syndrome with significant renal cystic and solid tumor disease. While the most common renal tumor in TSC, the angiomyolipoma, exhibits a loss of heterozygosity associated with disease, we have discovered that the renal cystic epithelium is composed of type A intercalated cells that have an intact Tsc gene that have been induced to exhibit Tsc‐ mutant disease phenotype. This mechanism appears to be different than that for ADPKD. The murine models described here closely resemble the human disease and both appear to be mTORC1 inhibitor responsive. The induction signaling driving cystogenesis may be mediated by extracellular vesicle trafficking. Abstract : TSC renal cystic disease develops in about half of the patients. The disease appears to caused by an induction mechanism such that a small population of mutant cells can cause significant renal cystic disease comprised of mostly genetically normal cells.